Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 468Neoplasms 332Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 235Lung Neoplasms 200Prostatic Neoplasms 182Carcinoma, Hepatocellular 175Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 115Uterine Cervical Neoplasms 111Rectal Neoplasms 103Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 80Ovarian Neoplasms 78Neoplasm Metastasis 77Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 64Endometrial Neoplasms 61Small Cell Lung Carcinoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Motor Activity 54Hematologic Neoplasms 54Disease 54Glioma 48

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Jaw Neoplasms × Clear all
NCT07552558 2026-06-03

Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Washington University School of Medicine

Phase 1/2 Not yet recruiting
45 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Jaw Neoplasms, Laryngeal Neoplasms, Lip Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡